For every new medication or pharmaceutical device, there is a list of side effects. In the case of implantable vena cava (IVC) filters, C.R. Bard and Bard Peripheral Vascular, Inc. downplayed the risks involved in keeping the filters in bodies extending past a few months. The purpose of the IVC filters is to stop blood clots that may result in death. Despite the caution involved, filters were implanted for long-term use in the 1970s. In the early 2000’s, the FDA approved the short-term use of IVC filters. It was possible for patients to receive the filter implants, even if taking medication was an alternative remedy. Read more